ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1949 • ACR Convergence 2025

    Relapsing Polychondritis: Mimicking Asthma while Airways get Damaged

    Eric Robbins1 and Marcela ferrada2, 1University of Maryland, baltimore, 2University of Maryland, Bethesda, MD

    Background/Purpose: Relapsing polychondritis (RP) is an autoimmune disorder that can present with airway inflammation, leading to dyspnea, cough, and fatigue. These respiratory symptoms are frequently…
  • Abstract Number: 1956 • ACR Convergence 2025

    68Ga-FAPI-04 and 18F-FDG PET/ CT in MDA5 dermatomyositis-associated interstitial lung disease: a single-center, pilot study

    Jia Li1, Weijun Wei2, Lianghua Li2, Wenwen Xu3, Jianjun Liu2 and Shuang Ye4, 1Department of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China (People's Republic), 2Department of Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200217, China., Shanghai, China (People's Republic), 3Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200217, China., Shanghai, China (People's Republic), 4Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China, Shanghai, Shanghai, China (People's Republic)

    Background/Purpose: Interstitial lung disease (ILD) is the leading cause of death in MDA5 dermatomyositis (MDA5-DM). Fibrosis and inflammation are pivotal drivers in the pathogenesis of…
  • Abstract Number: 1919 • ACR Convergence 2025

    Financial insecurity and discrimination are associated with patient-reported quality of life in patients with SLE

    Heather Gold1, Yi Li1, Peter Izmirly2, Jill Buyon1, Mala Masson3, Amit Saxena1, H Michael Belmont4, Chung-E Tseng5 and Rebecca Anthopolos1, 1NYU Grossman School of Medicine, New York, NY, 2New York University Grossman School of Medicine, New York, NY, 3NYU Langone Health, New York, 4NYU School of Medicine, New York, NY, 5New York University Grossman School of Medicine, Flushing, NY

    Background/Purpose: Manifestations of SLE are known to affect patient-reported outcome measures (PROs) such as physical function, fatigue, and pain. Other work has suggested economic insecurity…
  • Abstract Number: 1777 • ACR Convergence 2025

    Granzyme B as a regulator of interferon alpha production in cutaneous lupus erythematosus

    Touraj Khosravi1, Ahmed Eldaboush2, Darae Kang3 and Victoria Werth2, 1Department of Dermatology, Perelman Shool of Medicine, University of Pennsylvania, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA, 3University of Pennsylvania, Potomac, MD

    Background/Purpose: Recent studies have shown that monocytes, macrophages, and conventional DCs, but not plasmacytoid dendritic cells (pDC), are major sources of IFNα in cutaneous lupus…
  • Abstract Number: 1965 • ACR Convergence 2025

    Two-Year Outcomes of Microwave Ablation for Recurrent Monoarthritis with Synovial Hypertrophy Resistant to Medical Treatment: Expanded Cohort and Long-Term Follow-Up Results

    Rabia Deniz1, Tevfik Güzelbey2, İlhan Nahit Mutlu2, Kübra Kalkan3, Özgür Kılıçkesmez2 and Cemal Bes4, 1University of Health Sciences Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey, 2University of Health Sciences Başakşehir Çam and Sakura City Hospital, Department of Radiology, Istanbul, Turkey, 3University of Health Sciences Başakşehir Çam and Sakura City Hospital, Department of Rheumatology, Istanbul, Turkey, 4University of Health Sciences, Basaksehir Çam and Sakura City Hospital, Istanbul, Turkey

    Background/Purpose: Recurrent monoarthritis (RM) is a significant therapeutic challenge in rheumatology, often persisting despite NSAIDs, corticosteroids (CS), DMARDs, and biologic therapies. Local interventions like intra-articular…
  • Abstract Number: 1507 • ACR Convergence 2025

    Temporal Trends in the Incidence of Systemic Lupus Erythematosus (SLE) in the United States (US): Holding Steady?

    Sasha Bernatsky1, Sharon Dowell2, Brittany Banbury3, Jeffrey Curtis4, Grace Wright5, Emily Holladay6, Amy Mudano7, Cristiano Moura8 and Gail Kerr9, 1Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 2NEA Baptist Memorial Hospital, Jonesboro, AR, 3Mount Sinai Beth Israel, Brooklyn, NY, 4University of Alabama at Birmingham, Birmingham, AL, 5Grace C Wright MD PC, New York, NY, 6University of Alabama at Birmingham, Edmond, OK, 7Foundation for Advancing Science, Technology, Education and Research (FASTER), Birmingham, AL, 8Research Institute of the McGill University Health Center, Montréal, Canada, 9Washington DC VAMC/Georgetown and Howard Universities, Washington, DC

    Background/Purpose: Since SLE is associated with significant morbidity and healthcare burden, estimates of SLE incidence are needed to inform research and public health initiatives, including…
  • Abstract Number: 1909 • ACR Convergence 2025

    Trends of venous thromboembolism after total joint replacement in the United Kingdom after the introduction of NICE guidelines.

    Subhashisa Swain1, Nadja Leith2, Sarah Brown2, Cynthia Wright Drakesmith2, Jonathan Rees3, Clare Bankhead4 and John Powell4, 1Keele University, University of Oxford, Keele, United Kingdom, 2University of Oxford, Oxford, United Kingdom, 3NDORMS, University of Oxford, Oxford, United Kingdom, 4NDPCHS, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Joint replacement (JR) surgery is one of the preferred management for end-stage arthritis. Venous Thromboembolism (VTE) is one of the major post-surgical complications after…
  • Abstract Number: 1960 • ACR Convergence 2025

    Item Response Theory to Develop an Ultrasound Composite Score for Knee Osteoarthritis Assessment

    Liubov Arbeeva1, Carolina Alvarez2, Jonathan Samuels3, Janice Lin4, Minna Kohler5, Catherine Bakewell6, Todd Schwartz7 and Amanda Nelson8, 1University of North Carolina, Chapel Hill, Carrboro, NC, 2University of North Carolina at Chapel Hill, Miami, FL, 3NYU Langone, Rye Brook, NY, 4Stanford University, Palo Alto, CA, 5Massachusetts General Hospital, Harvard Medical School, Boston, MA, 6Intermountain Healthcare, Salt Lake City, UT, 7University of North Carolina-Chapel Hill, Chapel Hill, NC, 8University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Semi-quantitative scoring systems have long been used for radiographic findings in osteoarthritis (OA), but limited work has utilized ultrasound (US). The aim of this…
  • Abstract Number: 1928 • ACR Convergence 2025

    Oral Health in Patients with Rheumatic Diseases: A Pilot Quality Improvement Program

    Margarita Isabel Alarcon-Jarquin1, Fernanda M. Garcia-Garcia2, Vanessa L. Lopez-Flores1, Aleydis Gonzalez-Melendez3, Gabriel Figueroa-Parra3, Dionicio A. Galarza-Delgado2 and Janett C. Riega-Torres4, 1Rheumatology Service, University Hospital “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico, 3Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 4Rheumatology Service, Hospital Universitario “Dr. Jose Eleuterio Gonzalez”, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico

    Background/Purpose: Patients with rheumatic diseases commonly experience oral health issues such as dental caries, xerostomia, and periodontal disease. These complications are linked to both the…
  • Abstract Number: 1251 • ACR Convergence 2025

    Steroids and Me (Sam): engaging and educating steroid-treated patients via patient advocacy partnerships and internet search channels.

    Michelle Petri1, Martha Stone2, John Stone3, meredith Marinaro4, Matt Wilkinson5, Walter Lentfert6, Camille Kotton7, Jeffrey Gelfand8, Jane McDowell9 and Tricha Shivas10, 1Johns Hopkins University School of Medicine, Timonium, MD, 2Steritas, LLC, Concord, MA, 3Massachusetts General Hospital , Harvard Medical School, Concord, MA, 4Novartis, Hartford, CT, 5UpThereEverywhere, London, United Kingdom, 6UpThereEverywhere, Charlotte, NC, 7Harvard Medical School, Boston, MA, 8UCSF Department of Neurology, Mill Valley, CA, 9Queens University Belfast, Belfast, United Kingdom, 10Foundation for Sarcoidosis Research, Chicago, IL

    Background/Purpose: We report on two years of engagement with Sam, a patient-facing program to optimize the use of glucocorticoids and discontinue them when possible. We…
  • Abstract Number: 1904 • ACR Convergence 2025

    Mapping CTD-ILD in a Spanish Cohort – the NIRRVANA Registry

    Paula García-Escudero1, Marta López-Maraver2, Tetyana Lozinska-Lozinska2, Carlos Maria Lizasoain Alustiza3, César Antonio Egües Dubuc4, Leire Suárez Zorrilla5, Mayra Nathali Rivas Zavaleta5, Elena Garmendia Sánchez5, Nuria Vegas Revenga6, Myriam Aburto Barreneche7, Guillén Sada Urmeneta8, Elena Abad Plou9, Maria Luz Garcia Vivar10, Inmaculada Paniagua Zudaire11, Marta Inchausti Iguiñiz12, Iñaki Salegi Etxebeste12 and Jaime Calvo13, 1Hospital Universitario Álava, Bilbao, Spain, 2Hospital Universitario Araba, Vitoria, Spain, 3Donostia University Hospital, San Sebastian, Pais Vasco, Spain, 4Rheumatology Department, Donostia University Hospital., San Sebastian, Spain, 5Hospital Universitario Cruces, Barakaldo, Spain, 6Galdakao- Usansolo University Hospital, Galdakao, Spain, 7Hospital Galdakao-Usansolo, Galdakao, Spain, 8Hospital Reina Sofía de Tudela, Tudela, Spain, 9Hospital Universitario Basurto, Bilbao, Spain, 10Basurto Hospital, Bilbao, Spain, 11Hospital Universitario de Navarra, Pamplona, Spain, 12Hospital Universitario Donosti, Donosti, Spain, 13Department of Rheumatology, Hospital Universitario Araba, School of Medicne, Universidad del País Vasco, BIOARABA Health Research Institute, Vitoria, Spain, Vitoria, Pais Vasco, Spain

    Background/Purpose: Interstitial lung disease (ILD) is a prevalent feature among patients suffering from connective tissue diseases (CTD), associated with considerable morbi-mortality. Nonetheless, this complication is…
  • Abstract Number: 1959 • ACR Convergence 2025

    The development and validation of a Diagnostic Ultrasound Enthesitis Score (DUET) for Psoriatic Arthritis

    Lihi Eder1, Ricardo Acayaba de Toledo2, Catherine Bakewell3, Philippe Carron4, Basant Elnady5, Amir Haddad6, Arthur Kavanaugh7, Fahmeen J. Afgani8, Arnon Katz9, Minna Kohler10, josefina marin11, Nam Nguyen12, Adrien NZEUSSEU TOUKAP13, Ari Polachek14, Ernesto Rodriguez15, Marcos Rosemffet16, Abha Singh17, Maria S. Stoenoiu18, Agnes Szentpetery19, Iliara Tinazzi20, Janeth Yinh21, Mu Yang22, Richard Cook22, Gurjit Kaeley23 and Sibel Aydin24, 1University of Toronto, Toronto, ON, Canada, 2Centro Integrado de Pesquisas (CIP) do Hospital de Base de São José do Rio Preto, São José do Rio Preto, Brazil, 3Intermountain Healthcare Medical Group, Salt Lake City, 4Ghent University and VIB Center for Inflammation Research, Ghent, Belgium, 5Research Centre at Al Hada Armed Forces Hospital, Cairo, Egypt, 6Carmel Medical Center, Haifa, Israel, 7University of California, San Diego, School of Medicine, San Diego, CA, 8Women's College Hospital, Toronto, Canada, 9GRAPPA, Seattle, 10Massachusetts General Hospital, Harvard Medical School, Boston, MA, 11Hospital Universitario Rey Juan Carlos, Madrid, Spain, 12University of Toronto, Toronto, Canada, 13Cliniques Universitaires Saint-Luc, St.-Lambrechts-Woluwe, Belgium, 14Rheumatology Institute of Beilinson Hospital, Petah Tikva, Israel, 15Florida Medical Clinic, Tampa, 16Instituto de Rehabilitación Psicofísica, Capital Federal, Argentina, 17Altman Clinical and Translational Research Institute, University of California San Diego, San Diego, CA, 18Cliniques Universitaires Saint-Luc, Brussels, Belgium, 19Uppsala University Hospital, Djursholm, Sweden, 20Ospedale Sacro Cuore-Don Calabria, Verona, Italy, 21Massachusetts General Hospital, Boston, MA, 22University of Waterloo, Waterloo, Canada, 23UF COM-J, Ponte Vedra Beach, FL, 24Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Background/Purpose: Enthesitis is a key lesion in psoriatic arthritis (PsA). The Diagnostic Ultrasound Enthesitis Tool (DUET) study aimed to develop and validate a novel sonographic…
  • Abstract Number: 1964 • ACR Convergence 2025

    Performance of Artificial Intelligence-Based Salivary Gland Ultrasound in Sjögren Syndrome

    Otto Olivas1, Mónica García-Sevilla2, Lucía Cubero2, Javier Pascau2 and Esperanza Naredo3, 1Department of Rheumatology and Joint and Bone Research Unit. Fundación Jiménez Díaz University Hospital and Health Research Institute FJD-UAM, Madrid, Spain, Madrid, Madrid, Spain, 2Department of Bioengineering, Carlos III University of Madrid, Leganes, Madrid, Spain and Health Research Institute Gregorio Marañón, Madrid, Spain, Madrid, Madrid, Spain, 3Department of Rheumatology and Joint and Bone Research Unit. Fundación Jiménez Díaz University Hospital and Health Research Institute FJD-UAM, Madrid, Spain, MADRID, Spain

    Background/Purpose: To develop a deep learning model for classifying ultrasound images of salivary glands (SG) [parotid (PG) and submandibular (SMG)] based on the Outcome Measures…
  • Abstract Number: 1548 • ACR Convergence 2025

    Anifrolumab In Systemic Lupus Erythematosus. Spanish Multicenter Registry In Clinical Practice

    Vanesa Calvo-Río1, Carmen Secada-Gómez1, Miriam Retuerto Guerrero2, Judit Font-Urgelles3, Ivette Casafont-Solé3, Adrián Mayo-Juanatey4, Juan José Alegre-Sancho5, DALIFER FREITES6, Cristina Hormigos Martin7, Noemí Garrido8, GUILLERMO GONZALEZ ARRIBAS9, Juan Roberto Miguelez Sanchez10, Andrea García-Valle11, Marta Ibañez12, Fernando Lozano Morillo13, Ángel García Manzanares14, Sebastián Sandoval-Moreno15, Josefina Cortés-Hernández16, Deseada Palma-Sanchez17, LETICIA LOJO-OLIVEIRA18, Evelin Cervantes19, Paz Collado Ramos20, cristina arciniega Larios21, Luis Sala22, Eztizen Labrador-Sánchez23, Cilia Peralta-Ginés24, Nahia Plaza-Aulestia25, Irati Urionaguena Onaindia26, Miguel Medina Malone27, Jose Rosas Gómez de Salazar28, Montserrat Corteguera29, Laura Cebrian30, Fred Anton Pages31, Jose Ramón Lamua-Riazuelo32, María Dolores Fábregas Canales33, María José Alados Hernández34, Marta Garijo Bufort35, Anna Pamies36, Luis Sarabia37, Rodrigo Aguirre-del-Pino38, José Ángel Cabezas Lefler39, alvaro seijas38, Carmen Carrasco-Cubero40, Ana López-Cerón Cofiño41, Vera Ortiz-Santamaria42, Santos Castañeda43, Maria Laino44, Carmen Ordás Calvo45, Celia arconada46, ana Urruticoechea-Arana47, Blanca Garcia-Magallon48, Ana Valeria Acosta Alfaro49, Samuel Leal Rodriguez50, Marina Salido Olivares7, Patricia Lavilla Villar51, Anahy Maria Brandy3, Inmaculada Ros Vilamajo52, Alvaro García Martos53, Berta Magallares54, Guillen Sada Urmeneta55, Cristina Córdoba Martín56, Elena Riera Alonso57, Carmen Bejerano-Herreria58 and Ricardo Blanco,<58, 1Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 2Complejo Asistencial Universitario de Leon, Leon, Castilla y Leon, Spain, 3Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 4Hospital Universitario Doctor Peset, Valencia, Comunidad Valenciana, Spain, 5Hospital Universitario Doctor Peset, Valencia, Spain, 6Rheumatology Service, San Carlos Clinical Hospital, Madrid, Madrid, Spain, 7Hospital Clínico San Carlos, Madrid, Spain, 8Hospital Universitario Virgen del Rocío, Sevilla, Andalucia, Spain, 9Facultativo especialista, PALMA DE MALLORCA, Galicia, Spain, 10Department of Rheumatology, Hospital Universtiario de Móstoles, Madrid, Spain, Madrid, Madrid, Spain, 11Rheumatology. Hospital General Río Carrión, Palencia, Castilla y Leon, Spain, 12Hospital Universitario de la Santa Creu i Sant Pau, Barcelona, Catalonia, Spain, 13Hospital Central de La Defensa Gómez Ulla, Madrid, Madrid, Spain, 14Hospital Universitario de Torrevieja, Alicante, Spain, 15Hospital Universitario Vall D'Hebron, Barcelona, Spain, 16Hospital Universitari Vall d’Hebron-Universitat Autónoma de Barcelona, Barcelona, Spain, 17Rheumatology. Hospital Rafael Méndez, Lorca, Murcia, Spain, 18Hospital Universitario Infanta Leonor, Madrid, Spain, 19Hospital Provincial de Pontevedra, Pontevedra, Spain, 20Department of Rheumatology, Hospital Universitario Severo Ochoa, Madrid, Spain,, MADRID, Madrid, Spain, 21Hospital de Mérida, Badajoz, Spain, 22Hospital Universitario de Torrejón, Madrid, Spain, 23Hospital General de La Rioja, Logroño, Spain, 24Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 25Hospital Galdakao, Vizcaya, Spain, 26Rheumatology.Hospital Galdakao, Vizcaya, Pais Vasco, Spain, 27Hospital de Calahorra, Calahorra, Spain, 28Hospital Marina Baixa, PALMA DE MALLORCA, Spain, 29Rheumatology. Complejo Asistencial de Ávila, Ávila, Castilla y Leon, Spain, 30Department of Rheumatology, Hospital Universitario Infanta Leonor / Universidad Complutense de Madrid, Madrid, Spain, Madrid, Spain, 31Hospital General de Segovia, Segovia, Spain, 32Hospital Universitario del Henares, Madrid, Spain, 33Hospital de Barbastro, Huesca, Spain, 34Hospital Universitario Puerta del Mar, Cadiz, Spain, 35Hospital de Sagunto, Valencia, Spain, 36Hospital Verge de la Cinta, Tortosa, Tarragona, Spain, 37Complejo Hospitalario de Jaén, Jaén, Spain, 38Hospital Universitario Lucus Augusti, Lugo, Spain, 39Complejo Asistencial de Zamora, Zamora, Spain, 40Complejo Hospitalario Universitario de Badajoz, Badajoz, Spain, 41Hospital Santa Bárbara, Soria, Spain, 42Hospital General de Granollers, Barcelona, Spain, 43Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Madrid, Spain, 44Hospital Universitario de Navarra, Pamplona, Spain, 45Hospital Universitario de Cabueñes, Gijón, Spain, 46Hospital universitario de Getafe, Getafe, Madrid, Spain, 47Rheumatology Division. Hospital Universitario Son Espases, Palma de Mallorca, Spain, 48Rheumatology, Hospital Universitario Puerta de Hierro, Madrid, Spain, 49Hospital Universitario Infanta Sofia; Universidad Europea de Madrid; FIIB HUIS-HUHEN, Madrid, Spain, 50Hospital Universitario La Fe, Valencia, Valencia, Spain, 51Hospital General de Villalba, Collado Villalba, Madrid, Spain, 52Hospital Son Llàtzer, Palma de Mallorca, Spain, 53Hospital del Tajo, Aranjuez, Madrid, Spain, 54Hospital de Sant Pau, Barcelona, Spain, 55Rheumatology, Hospital Reina Sofía, Tudela, Spain, 56Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Tenerife, Spain, 57Hospital Universitari Mùtua Terrassa, Terrassa, Spain, 58Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.

    Background/Purpose: Anifrolumab (ANI) is a human monoclonal antibody that binds to the type I interferon receptor subunit 1 (IFNAR1). ANI was approved by Spanish authorities…
  • Abstract Number: 1954 • ACR Convergence 2025

    Revolutionizing Microvascular Screening: AI-Powered Dermatoscopy for Efficient Nailfold Capillary Evaluation

    Genessis Maldonado1, Eduardo Ramos ibáñez2, Borja del Carmelo Gracia Tello3 and Tracy Frech4, 1Vanderbilt University Medical Center, Nashville, 2Capillary.io, Zaragoza, Aragon, Spain, 3Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 4Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Nailfold capillaroscopy plays a critical role in the diagnosis and management of systemic sclerosis (SSc) and related connective tissue diseases. However, access to capillaroscopy…
  • « Previous Page
  • 1
  • …
  • 131
  • 132
  • 133
  • 134
  • 135
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology